@article{caf44dce2986441e9cad6cb8218b954b,
title = "Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling after Myocardial Infarction: A Randomized Clinical Trial",
author = "Boyle, \{Andrew J.\} and Boyle, \{Andrew J.\} and Carl Schultz and Carl Schultz and Selvanayagam, \{Joseph B.\} and Stuart Moir and Richard Kovacs and Nabil Dib and David Zlotnick and Mohammed Al-Omary and Mohammed Al-Omary and Stuart Sugito and Aravinda Selvarajah and Nicholas Collins and Nicholas Collins and Grant McLachlan",
note = "Importance After anterior ST-segment elevation myocardial infarction (STEMI), left ventricular (LV) remodeling results in heart failure and death. Calcium/calmodulin-dependent protein kinase II delta (CaMKIId) is a key molecular mediator of adverse LV remodeling. Objective To determine whether NP202, an orally active inhibitor of CaMKIId, prevents LV remodeling in patients after anterior STEMI with early residual LV dysfunction.",
year = "2021",
month = apr,
day = "14",
doi = "10.1001/JAMACARDIO.2021.0676",
language = "American English",
volume = "6",
journal = "JAMA Cardiology",
issn = "2380-6591",
publisher = "American Medical Association",
number = "7",
}